U.S. patent number RE38,509 [Application Number 09/916,905] was granted by the patent office on 2004-05-04 for on site machine readable if assaying system.
This patent grant is currently assigned to eScreen, Inc.. Invention is credited to Murray Lappe.
United States Patent |
RE38,509 |
Lappe |
May 4, 2004 |
On site machine readable IF assaying system
Abstract
A machine readable assaying system comprising a test card having
machine readable assaying means. A plurality of individual analysis
strips, each strip comprising antibodies and/or reagents capable of
indicating the positive presence of distinct illicit substances
form a pattern of elements including one or more fixed strips and
one or more blank regions. The detection of the presence of a
particular substance or drug will result in one or more of the
analysis strips changing from a first (light reflective) color to a
second darker (light absorbent) color. The pattern of analysis
strips, fixed strips and blank regions may be provided to encode
one or more characters/digits of information. By the inclusion of
the analysis strips with the plurality of fixed strips and blank
regions, the detection of one or more illicit substances may alter
the overall pattern of fixed and test strips and blank regions, and
hence cause the encoded information represented thereby to be
altered. Accordingly, the particular pattern of bars and spaces
that result from an exposure the physiological fluids of a donor is
contemplated to produce a distinct machine readable indicia. The
transformation which occurs on the test card will be
uninterpretable by the administrator of the test, thus preserving
the anonymity and privacy of the tested individual.
Inventors: |
Lappe; Murray (Beverly Hills,
CA) |
Assignee: |
eScreen, Inc. (Overland Park,
KS)
|
Family
ID: |
32180054 |
Appl.
No.: |
09/916,905 |
Filed: |
July 26, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
Reissue of: |
832957 |
Apr 4, 1997 |
05929422 |
Jul 27, 1999 |
|
|
Current U.S.
Class: |
235/462.13;
235/462.01; 235/462.04; 422/562 |
Current CPC
Class: |
B01L
3/545 (20130101); G01N 33/528 (20130101); G06K
19/06028 (20130101); B01L 3/5023 (20130101); B01L
2200/0605 (20130101); B01L 2200/141 (20130101); B01L
2300/021 (20130101); B01L 2300/042 (20130101); B01L
2300/046 (20130101); B01L 2300/047 (20130101); B01L
2300/0663 (20130101); B01L 2300/069 (20130101); B01L
2300/0832 (20130101); B01L 2400/0406 (20130101); B01L
2400/0478 (20130101); G06K 2019/06253 (20130101) |
Current International
Class: |
B01L
3/00 (20060101); G01N 33/52 (20060101); G06K
19/06 (20060101); G06F 007/10 (); G01N
033/00 () |
Field of
Search: |
;235/462,462.01,462.04,462.13,499,375 ;422/56,66 ;435/4 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Dunn; Drew A.
Attorney, Agent or Firm: Williams LLP; Hovey
Claims
What is claimed is:
1. An on-site machine readable assaying system for detecting the
absence of prescribed substances in human physiological fluids such
as urine, said fluids emanating from a donor individual,
comprising: a) a test card; and b) machine readable assaying means
comprising at least one individual analysis strip imprinted upon
the test card, each analysis strip consisting of reagents which are
capable of analyzing, detecting and visually signaling the presence
of proscribed substances within human physiological fluid, at least
one fixed strip and at least one blank region also located upon the
test card, organized in a pattern with the individual analysis
strips to produce an encoded machine readable source of data,
wherein the analysis strips, upon detecting a proscribed substance,
will change from a first color to a second darker color, hence
altering the initial pattern of fixed strips, blank regions and
analysis strips, thus producing encoded data which is distinct from
that data which was previously encoded therein.
2. The on-site machine readable assaying system of claim 1, wherein
adulteration detection means which are capable of determining
whether a particular specimen of physiological fluid such as urine
has been tampered with are located upon the test card.
3. The on-site machine readable assaying system of claim 2, further
comprising quality control indication means which are configured to
generate a signal upon contact with physiological fluid, regardless
of the presence of proscribed substances, to ensure that the
analysis strips of the machine readable assaying means are
functioning properly.
4. The on-site machine readable assaying system of claim 3, wherein
the adulteration detection means and quality control indication
means are configured within the pattern of analysis strips, fixed
strips and blank regions which comprise the machine readable source
of data.
5. The on-site machine readable assaying system of claim 4, wherein
a machine readable pattern encoding test card production
information is located upon the test card.
6. The on-site machine readable assaying system of claim 5, further
comprising alignment aids located upon the test card for assisting
in the alignment of the test card for reading by an appropriate
device.
7. The on-site machine readable assaying system of claim 1, further
comprising a) a test card reading unit for scanning and decoding
the encoded machine readable data source on the test card; b) a
controller module comprising a processor and a memory unit, the
processor capable of processing and the memory unit of storing the
decoded machine readable source of data gathered by the test card
reading unit; and c) a communication module and a communication
link, the communication module capable of transmitting the decoded
data processed by the processor and stored in the memory unit to a
distinct location such as a central laboratory via the
communication link.
8. The on-site machine readable assaying system of claim 2, further
comprising a) a test card reading unit for scanning and decoding
the encoded machine readable data source on the test card; b) a
controller module comprising a processor and a memory unit, the
processor capable of processing and the memory unit of storing the
decoded machine readable source of data gathered by the test card
reading unit; and c) a communication module and a communication
link, the communication module capable of transmitting the decoded
data processed by the processor and stored in the memory unit to a
distinct location such as a central laboratory via the
communication link.
9. The on-site machine readable assaying system of claim 7, further
comprising a user interface module, the user interface module
having a keyboard for allowing an individual to input certain data
which is transmitted by the communication module along with the
decoded and processed information gathered by the test card reading
unit.
10. The on-site machine readable assaying system of claim 8,
further comprising a user interface module, the user interface
module having a keyboard for allowing an individual to input
certain data which is transmitted by the communication module along
with the decoded and processed information gathered by the test
card reading unit.
11. A method of utilizing the on-site machine readable assaying
system of claim 7, comprising the steps of: a) bringing the volume
of physiological fluid which has emanated from the donor into
contact with the machine readable assaying means located upon the
test card; b) allowing a fixed period of time to elapse; and c)
placing the test card reading apparatus adjacent to the test card,
in order to scan and decode the encoded machine readable data
source contained thereon.
12. The method of claim 11, further comprising the step of: a)
transmitting the decoded data to a distinct location, by means of
the communication link.
13. A machine readable system comprising: a) a test surface having
machine readable bar-code indicia imprinted thereupon; and b)
analysis means configured within said machine readable bar-code
indicia, capable of detecting and optically signaling the presence
of a desired state, wherein the analysis means, upon detecting said
state, cause the configuration of the machine readable bar-code
indicia to change from a first configuration to a second
configuration, thus producing encoded data in the second
configuration which is distinct from that data which was previously
encoded in the first configuration. .Iadd.
14. An assaying system for detecting the presence or absence of a
proscribed substance in a human physiological fluid, said fluid
emanating from a donor individual, said system comprising: a test
surface adapted to be contacted with said sample and having at
least one machine readable indicium thereon, said indicium having
an initial state and being capable of changing to an altered state
in response to contact with said fluid; and an adulteration
detector capable of detecting whether said fluid has been tampered
with, said detector located proximal to said indicium.
.Iaddend..Iadd.
15. The system of claim 14, said surface, indicium and detector
supported on a test card. .Iaddend..Iadd.
16. The system of claim 14, further comprising quality control
indication means configured to generate a signal upon contact with
said physiological fluid, regardless of the presence or absence of
said proscribed substance, to ensure that said indicium is
functioning properly. .Iaddend..Iadd.
17. The system of claim 14, said indicium comprising reagents
capable of analyzing, detecting and visually signaling the presence
or absence of said proscribed substance within said fluid.
.Iaddend..Iadd.
18. The system of claim 14, there being a plurality of machine
readable indicia on said test surface. .Iaddend..Iadd.
19. The system of claim 18, said indicia being individual analysis
strips, there being at least one fixed strip and at least one blank
region on the test surface, said fixed strip, said individual
analysis strips, and said blank region organized in a pattern with
the individual analysis strips to produce an encoded machine
readable source of data, wherein the analysis strips, upon
detecting said proscribed substance, will change from a first color
to a second darker color, hence altering the initial pattern of
fixed strips, blank regions and analysis strips, thus producing
encoded data which is distinct from that data which was previously
encoded therein. .Iaddend..Iadd.
20. The system of claim 14, said indicium being uninterpretable by
a test administrator. .Iaddend..Iadd.
21. A method of carrying out a plurality of tests at test
locations, each test to detect the presence or absence of at least
one proscribed substance in a respective human physiological fluid
sample emanating from a donor individual, said method comprising
the steps of: providing at the test locations (1) a test surface
adapted to be contacted with a respective fluid sample and having
at least one machine readable indicium thereon, said indicium
having an initial state and being capable of changing to an altered
state in response to contact with the respective sample, said test
surface having an adulteration detector capable of determining
whether said fluid has been tampered with and (2) a test card
scanning unit capable of scanning the machine readable indicium on
said surface; contacting a test surface with a respective fluid
sample; after said contacting step, using a scanning unit to scan
said at least one indicium, and generating test result data as a
result of said scan; and transmitting said result data using a
communications link to a distinct location. .Iaddend..Iadd.
22. The method of claim 21 including the step of analyzing the
result data from each of said test locations at said distinct
location. .Iaddend..Iadd.
23. The method of claim 21, wherein said test surface comprises
quality control indication means configured to generate a signal
upon contact with said physiological fluid, regardless of the
presence or absence of said proscribed substance, to ensure that
said indicium is functioning properly. .Iaddend..Iadd.
24. The method of claim 21, said indicium comprising reagents
capable of analyzing, detecting and visually signaling the presence
or absence of said proscribed substance within said fluid.
.Iaddend..Iadd.
25. The method of claim 21, there being a plurality of machine
readable indicia on each of said test surfaces. .Iaddend..Iadd.
26. The method of claim 25, said indicia being individual analysis
strips, there being at least one fixed strip and at least one blank
region on each test surface, said fixed strip, said individual
analysis strips, and said blank region organized in a pattern with
the individual analysis strips to produce an encoded machine
readable source of data, wherein the analysis strips, upon
detecting said proscribed substance, will change from a first color
to a second darker color, hence altering the initial pattern of
fixed strips, blank regions and analysis strips, thus producing
encoded data which is distinct from that data which was previously
encoded therein. .Iaddend..Iadd.
27. The method of claim 21, said indicium being machine readable
only and not human interpretable in the absence of said machine
reading so that others viewing said indicium after said contact
with said sample are unable to directly interpret the results of
the individual's test without said machine reading.
.Iaddend..Iadd.
28. An on-site machine readable assaying system for detecting the
presence or absence of proscribed substances in human physiological
fluids such as urine, said fluids emanating from a donor
individual, comprising: a) a test card; and b) machine readable
assaying means comprising at least one individual analysis strip
imprinted upon the test card, each analysis strip comprising
reagents which are capable of analyzing, detecting and visually
signaling the presence or absence of proscribed substances within
human physiological fluid, at least one fixed strip and at least
one blank region also located upon the test card, organized in a
pattern with the individual analysis strips to produce an encoded
machine readable source of data, wherein the analysis strips, upon
detecting a proscribed substance or absence thereof, will change
from a first light color to a second darker color, or visa-versa,
hence altering the initial pattern of fixed strips, blank regions
and analysis strips, thus producing encoded data which is distinct
from that data which was previously encoded therein.
.Iaddend..Iadd.
29. A method of carrying out a plurality of tests at test
locations, each test to detect the presence or absence of at least
one proscribed substance in a respective human physiological fluid
sample emanating from a donor individual, said method comprising
the steps of: providing at the test locations (1) a test surface
adapted to be contacted with a respective fluid sample and having a
plurality of machine readable indicium thereon, said indicium
having an initial state and being capable of changing to an altered
state in response to contact with the respective sample, and (2) a
test card scanning unit capable of scanning the machine readable
indicium on said surface, said indicia being individual analysis
strips, there being at least one fixed strip and at least one blank
region on each test surface, said fixed strip, said individual
analysis strips, and said blank region organized in a pattern with
the individual analysis strips to produce an encoded machine
readable source of data, wherein the analysis strips, upon
detecting said proscribed substance, will change from a first color
to a second darker color, hence altering the initial pattern of
fixed strips, blank regions and analysis strips, thus producing
encoded data which is distinct from that data which was previously
encoded therein; contacting a test surface with a respective fluid
sample; after said contacting step, using a scanning unit to scan
said at least one indicium, and generating test result data as a
result of said scan; and transmitting said result data using a
communications link to a distinct location. .Iaddend..Iadd.
30. A method of carrying out a plurality of tests at test
locations, each test to detect the presence or absence of at least
one proscribed substance in a respective human physiological fluid
sample emanating from a donor individual, said method comprising
the steps of: providing at the test locations (1) a test surface
adapted to be contacted with a respective fluid sample and having
at least one machine readable indicium thereon, said indicium
having an initial state and being capable of changing to an altered
state in response to contact with the respective sample, and (2) a
test card scanning unit capable of scanning the machine readable
indicium on said surface; contacting a test surface with a
respective fluid sample; after said contacting step, using a
scanning unit to scan said at least one indicium, and generating
test result data as a result of said scan; and transmitting said
result data using a communications link to a distinct location,
said indicium being machine readable only and not human
interpretable in the absence of said machine reading so that others
viewing said indicium after said contact with said sample are
unable to directly interpret the results of the individual's test
without said machine reading. .Iaddend.
Description
BACKGROUND OF THE INVENTION
The invention relates to an assaying system. More particularly, the
invention relates to a machine readable assaying system for
analyzing a specimen of physiological fluid to detect the presence
or absence of particular substances therein. In a preferred
embodiment, the machine readable assaying system contemplates the
utilization of machine readable bar-code patterns imprinted upon a
test card which change form in response to a physical, chemical or
biological reaction. The test result which is encoded within the
bar-code indicia imprinted upon the test card is read by an
appropriate decoding apparatus (i.e. a bar-code reader/scanner),
and the decoded results are stored in a memory unit and
transmitted, if desired, to a distinct location. A test
administrator merely scans the bar-code. Because the bar-code
patterns change form in such a subtle yet varied manner, the
administrator or another observer of the test card is unable to
discern the results. Accordingly, the privacy interests of the
donor are preserved, as well as human interpretation errors,
transcription and translation errors.
The increase in drug use over the past several decades has created
a sharp need for more effective, expeditious methods of analyzing
whether a particular individual is a user of certain illegal
substances. Both private industry employers as well as governmental
employers often need to determine whether an individual has drug
residue present in his or her biological system, and hence
determine whether such an individual is a drug user or drug abuser
and thus an unqualified employee.
Typically, the status of an individual as a drug user or abuser is
determined by analysis of the individual's physiological fluids,
namely urine. A specimen of urine is collected, and a highly
sensitive screening test is first performed, usually at a
centralized laboratory. If specimen samples screen positive at the
central laboratory, then a more sensitive and controlled
confirmation analysis must be performed.
In addition to being an extremely costly process, the above
mentioned procedure also involves great time delays to employers
desirous of obtaining new qualified employees. Upon collection of
the urine sample, the employer must wait to receive test results
from the central laboratory before hiring any potential employees.
Furthermore, the massive amount of handling and transfer of the
sample of urine from the initial collection site to the central
laboratory.
To combat the above mentioned timeliness problem which faces many
employees in awaiting results from the central laboratory, various
"on-site" or "hand-held" assaying devices have been developed. A
major problem inherent in these "on-site" testing devices is that
the privacy concerns of the potential employee being tested are not
adequately addressed. Since all of the on-site testing devices
available heretofore attempt merely to identify drugs present (i.e.
simply to indicate which specimens do indeed possess the prohibited
substance/drug), the anonymity of a presumptive positive donor is
impossible to conceal. Due to such lack of anonymity, many
employers (governmental in particular) will not employ such an
assaying system as it does not comply with federally mandated
regulations regarding privacy and civil liberties during
drug-employment testing. A more anonymous, reliable and expeditious
assaying system is needed, wherein negative results can be obtained
quickly without compromising the privacy concerns of the tested
individual. The results are not "human readable" and thus are not
subject to interpretation.
SUMMARY OF THE INVENTION
It is an object of the invention to produce an assaying system for
analyzing a specimen of body fluid to detect the absence of
particular substances therein.
It is another object of the invention to provide an assaying system
which provides more anonymous, reliable and expeditious results
than those assaying systems presently found in the art, wherein
said results can be obtained quickly without compromising the
privacy concerns of the tested donor individual.
It is a further object of the invention to provide an on-site,
portable assaying system which allows the results of said assay to
be determined and utilized almost immediately by an employer,
without jeopardizing the privacy rights of the individual being
tested.
It is a still further object of the invention to provide an
assaying system which allows the results of said assay to be
encoded in a machine readable format (such as bar-coding) such that
said encoded results are visually undetectable and must be de-coded
by appropriate apparatus. Accordingly, the administrator of the
assay lacks access to the test results.
It is yet another object of the invention to provide an assaying
system which possesses a memory unit to store resultant decoded
assay data, and communication means for transmitting said decoded
data to a distinct location (such as a central
laboratory/processing office). Upon receiving the assay data, the
central laboratory/processing office could then electronically,
telephonically or manually (via a delivered hard copy) communicate
a responsive "negative test certificate" to the employer for those
individuals testing negative (indicating that these individuals are
candidates for immediate employment). A sample specimen of
physiological fluid from only those individuals who tested positive
would then be requested by the central laboratory for standard
"confirmation" testing.
It is yet another object of the invention to provide an assaying
system such as that discussed above which possesses means capable
of detecting adulteration of the specimen.
To the accomplishment of the above and related objects the
invention may be embodied in the form illustrated in the
accompanying drawings. Attention is called to the fact, however,
that the drawings are illustrative only. Variations are
contemplated as being part of the invention, limited only by the
scope of the claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1A illustrates a diagrammatic perspective view of a test card
of an on-site machine readable assaying system.
FIG. 1B illustrates an enlarged portion of the embodiment of the
test card of FIG. 1A.
FIG. 2 is a high level functional diagram of an embodiment of an
assaying system apparatus to read/interpret the test card of FIG.
1A in accordance with the invention.
FIG. 3 provides a more detailed block diagram of an embodiment of
if the apparatus of FIG. 2.
FIG. 4 provides another embodiment of an apparatus to
read/interpret test cards of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
FIG. 1 depicts a test card 22 of an on-site machine readable
assaying system, having various indicia inscribed thereupon. More
specifically, the test card 22 possesses machine readable assaying
means 32 (also to be referred to hereafter as an encoded machine
readable data source). The machine readable assaying means 32
preferably comprise in part a plurality of individual analysis
strips 34, each consisting of antibodies and/or reagents capable of
chemically analyzing a sample volume of urine to detect a positive
presence of a particular substance (such as marijuana, opiates,
amphetamines, cocaine, PCP, etc.). Traditionally, assaying means in
this particular field were configured merely to visually indicate
the positive presence of particular substances. If a "positive"
indication was given, it was automatically inferred that the donor
individual who provided the urine was a drug user/abuser (although
secondary testing is always conducted to confirm these results).
This system posed great threats to individual privacy and civil
liberty concerns, and hence proved unsatisfactory. The employment
of the assaying means by the instant invention, however, addresses
these deficiencies.
As seen in detail in FIG. 1B, the plurality of individual analysis
strips 34 are illustrated as an essential component of the machine
readable assaying means 32 (also referred to as bar code indicia).
As mentioned earlier, each of said analysis strips 34 consists of
the antibodies and/or reagents which are capable of visually
indicating the positive presence of distinct illicit substances. In
particular, the machine readable assaying means 32 may be formed,
as shown in FIG. 1B, of a pattern of elements including one or more
fixed strips 33a, one or more blank regions 33b, and the analysis
strips 34 to produce the encoded machine readable data source. In a
preferred embodiment, the detection of the presence of a particular
substance or drug will result in one or more of the analysis strips
34 changing from a first (light reflective) color to a second
darker (light absorbent) color--or visa versa.
As seen in the arrangement depicted in FIG. 1B, the pattern of
analysis strips 34, fixed strips 33A, and blank regions 33B (which
may also be termed "bars" and "spaces" by those skilled in the
art), when configured to comprise the encoded machine readable data
source may be provided to encode one or more characters/digits of
information or other data. Accordingly, by the inclusion of the
analysis strips 34 along with the plurality of fixed strips 33a and
blank regions 33b, the detection of one or more illicit substances
may cause the overall pattern of fixed 33A and test 34 strips
(bars) and blank regions 33B (spaces) to vary, and hence the
encoded information represented thereby to be altered. For example,
machine readable assaying means 32 comprising the encoded machine
readable data source may be comprised of one or more bar code
indicia whose pattern of bars and spaces (and associated coded
digits) is altered in accordance to the particular substances
detected via the inclusion and appearance of one or more analysis
strips 34 within the bar code indicia. Accordingly, the particular
pattern of bars and spaces that result from an exposure the
physiological fluids of a donor, as provided by the machine
readable assaying means 32, is contemplated to produce a distinct
machine readable indicia.
It is contemplated in the preferred embodiment that one or more of
the individual analysis strips 34 which comprise the bar code
indicia of the machine readable assaying means 32 contain reagents
or antibodies whose visual appearance is altered in response to
physiological fluid, regardless of whether any illicit drugs are
present within said fluid. It is further contemplated that these
"control" analysis strips 34C be situated such that their detection
amongst the pattern of strips 33A and 34 and blank regions 33B
(bars and spaces) comprising the bar code indicia does not vary the
character of the information encoded therewithin. For instance, the
bar code indicia of the machine readable assaying means 32 would
indicate, if decoded by an appropriate device prior to contact with
physiological fluid, a negative presence of illicit drugs. Upon
contact with a volume of physiological fluid which lacks the
presence of illicit drugs, the "control" analysis strips 34C will
appear. However, their placement amongst the standard test strips
34, fixed test strips 33A and blank regions 33B will not effect the
initial encoded character of the bar code indicia. Accordingly, a
negative assay will be determined.
The function of the "control" analysis strips 34 is to prevent an
administrator of the test from learning the outcome of the assay.
If, subsequent to the administration of each assay, some type of
change occurs to the visual appearance of the machine readable
assaying means 32, then the test administrator will be unable to
discern positive test results from negative results. Only the
device used to decode the encoded bar code indicia will be able to
determine whether the donor's specimen of physiological fluid tests
positive for illicit drugs, and if so, which particular substances
were present.
The test card 22 of FIG. 1A also possesses adulteration detection
means 36. Said adulteration detection means 36 are capable of
determining whether a particular specimen of urine or other
physiological fluid has been tampered with by administering either
channel analysis (to ensure that the chemical composition of said
specimen is consistent with that of standard, non-adulterated human
urine) and/or temperature analysis (to ensure that the specimen has
been recently excreted from the donor and has not been brought to
the test site by the donor from an earlier excretion). Furthermore,
quality control indication means 38 are also present upon said test
cards 22 to ensure that the reagents of the analysis strips 34 are
functioning properly. Said quality control indication means 38 are
configured to generate a signal upon contact with urine or other
physiological fluids, regardless of the presence of illicit
substances, to indicate that the analysis strips 34 have not been
degraded due to improper storage, etc. If the quality control
indication means 38 fail to generate a signal upon contact with the
urine, the test card 22 should be discarded.
Further included upon the test card 22 of FIG. 1A is an
identification code 42, which may be provided as a pattern encoding
items such as production batch numbers of the test card, a date of
manufacture, etc. It is important to note that the identification
code 42 pattern represents a machine readable (and decodeable)
pattern, and as such may easily be "read" by a suitable device and
received by a computer or controller means for processing,
dissemination, or other appropriated actions.
Also seen in FIG. 1A are alignment aids 46 that may be provided to
aid in the alignment of the test card 22 for reading or scanning by
a properly arranged device. It is important to note that other
arrangements of the identification code 42, the quality control
indication means 38, the adulteration means 36, and the assaying
means 32 are possible and contemplated. For example, skilled
persons will appreciate modifications such as including the quality
control indication means 38 and the adulteration means 36 within
the elements composing the assaying means 32, as seen in FIG. 1B.
Accordingly, quality control indication means 38 and the
adulteration means 36 may determine the overall "coding" provided
by said assaying means 32. In one embodiment of the instant
invention, it is contemplated that the quality control indication
means 38 be incorporated with the "control" test strips 34 and
situated such that their detection amongst the pattern of strips
33A and 34 and blanks 33B (bars and spaces) comprising the bar code
indicia does not vary the character of the information encoded
therewithin. Still other modifications are possible and
contemplated.
Turning now to FIG. 2, there is provided a high level functional
diagram of a test card reading apparatus 60. As shown, a test card
reading unit 54 is included, which is operatively coupled to a
control and communication means 56. The test card reading means 54
is provided to "read" and determine the particular patterns present
on the test card 22. As such, the reading of the patterns of the
test card 22 may result in a plurality of digits or characters
being determined (or generated) by the test card reading units 54,
which may be communicated to a control and communication means 56.
Subsequently, the received characters may be transmitted, via a
communication link 66, to a central laboratory 58 for checking,
decoding, and or general evaluation. Therefore, the pattern of the
assaying means 32, the condition of the adulteration detection
means 36 and the quality control indication means 38, and the
identification code may be provided as "machine readable" and may
be transmitted in an anonymous and confidential manner to the
central laboratory 58, in accordance with the privacy features of
present invention. Those skilled in the art will appreciate the
available means to embody the test card 22 of FIG. 1A, and further
may provide modifications and alterations to the embodiments of the
test card reading apparatus 60 of FIGS. 2 and 3.
One possible embodiment of the test card reading apparatus 60 is
seen in FIG. 3. Included is a scanner 54a and decoder 54b
configured to read the test card 22 and decode the plurality of
patterns associated thereon. The patterns may include the assaying
means 32, the identification code 42, the adulteration detection
means 36, and the quality control indication means 38. A controller
module 62 is provided to establish the functional characteristics
of the test card reading apparatus 60. The controller module 62 may
be embodied as shown by providing a processor 62a, a memory unit
62b (providing a suitable application program), and any required
interface circuitry 62c. The controller module may be arranged to
receive from the decoder information including one or more
(decoded) digits or characters. The information may then be
transmitted by a communication module 63 via the communication link
66 to the central laboratory 58. The information processed and or
transmitted to the central laboratory 58 for analysis. Also shown
is a user interface module 64 to enable an individual to enter
information into the test card reading apparatus 60 and provide
information to said individual. The user interface may include
known items such as a display 64a, a keyboard 64b, an audio unit
64c, and printer 64d. For example, an identification code such as
the donor's social security number may be keyed into the keyboard
64B of the user interface module 64 and transmitted via the
communication link 66 to the central laboratory 58. Other user
interface items may also be provided (which are not shown in FIG.
3) including pointing devices, a fax transmission module, touch
screen displays, etc.
It should be noted that the controller module 62 may be provided by
known programmable single chip microcomputers and any additional
analog/digital circuitry required. Further, it is contemplated that
the controller module 62 may be provided (in an alternate
embodiment to that shown in FIG. 3) by one or more programmable
logic devices (PLDs), or by discrete components including digital
MSI and LSI logic functions. Those skilled in the art will
appreciate the plethora of commercially available (off-the-shelf)
devices and components that may be utilized to embody the
controller module 62 and the communication module 63. Also,
although the scanner 54b may in a preferred embodiment be realized
by a laser scanning device, other suitable devices, such as a CCD
imaging device may be employed. It is also contemplated that the
test card reading apparatus 60 may be realized by a properly
configured personal or workstation computer. For example, an
IMB.RTM. compatible personal computer (PC) may be arranged with a
scanner 54a, a fax modem or networking card, etc. In such an
embodiment, the functionality of the test card reading apparatus 60
may be provided by the execution of an (custom) application
program. Therefore, it should be understood that the embodiments of
the FIGS. 3 and 4 are illustrative of a number of possible
embodiments, which may be provided by skilled persons.
Another embodiment of the test card reading unit 54 of FIG. 2 is
provided in FIG. 4. An important feature of this invention is the
use of an "interpretation means", such as interpreter 72, which
will "read" the test card 22, along with an encoder 76 that may be
employed to generate (e.g. print) a result summary 82. The result
summary 82 is contemplated to include one or more printed bar code
indicia. In a preferred embodiment of the present invention, the
result summary 82 may be provided (printed) using standard bar code
symbologies (such as Code 39, Interleaved 2 of 5, PDF417, etc.),
and accordingly could be read using "off-the-shelf" scanning
devices and decoders to provide scanner 54a and decoder 54b of FIG.
3. An advantage of the arrangement of FIG. 4, is that the assaying
means 32 need not be configured initially in a "standard" bar code
indicia. For instance, rather than configuring the machine readable
assaying means 32 in standard bar code language format, a
customized configuration can be employed (by using, for instance,
optical scan sheets). It is the function of the interpreter 72 and
the encoder 76 to then decipher this customized configuration and
provide a standard bar code indicia (that is scannable by low cost
and known devices and apparatus).
The aforementioned configuration of the machine readable assaying
system of the instant invention render said system capable of being
employed on-site at an employer's individual location. A donor
individual is given a collection container and provided a private
environment where said donor individual is to excrete a specimen
volume of urine into the collection container for analysis. A
volume of urine is then brought into contact with the test card 22
(by bathing the test card 22 with a small amount of urine,
inserting the test card 22 into the urine, etc.) The quality
control indication means 38 and/or the control test strips 34 are
then checked to assure the integrity of the assaying means 32.
Assuming that the assay is functioning properly, the adulteration
detection means 36 are then checked to determined whether the donor
individual tampered with the specimen. If the adulteration
detection means 36 indicate that the specimen is unadulterated,
then the machine readable assaying means 32 are then read by the
test card reading unit 54 (such as the scanner 54a and decoder
54b). The results of the assay are then stored in the memory unit
62B of the controller module 62 for transmission to a desired
location such as the centralized laboratory 58.
Upon the central laboratory 58 receiving the assay data, the names
or identification codes of those donor individuals who provided
negative results may be immediately communicated to prospective
employers, so that those particular donors may be offered
employment. All positive assay urine specimens will be requested
from the test site by the central laboratory 58 for further
confirmation analysis. Accordingly, the employer is immediately
provided with a number of qualified potential employees to choose
from, and the privacy concerns of the donor individual are
safeguarded.
* * * * *